GSK3B and Alzheimer disease: Specifically, a loss-of-function mutation in LRP6 has been identified as a risk factor for AD (De Ferrari et al., 2007), as have gain-of-function mutations in the GSK3β gene (Schaffer et al., 2008; Figure 1C).